CTOs on the Move

Casana Care

www.casanacare.com

 
Casana is changing the way healthcare does business with a smart toilet seat that enables effortless, integrated, and consistent in-home health monitoring. The Heart Seat™ captures key clinical measurements, including heart rate, blood pressure, and blood oxygenation, to assist medical teams with monitoring chronic conditions beyond the four walls of the hospital. The healthcare system has been searching for this actionable intelligence for decades, and it turns out, we were sitting on a great idea all along.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details
Samir Zahine
Chief Technology Officer Profile

Funding

Casana Care raised $14M on 02/03/2021

Similar Companies

Joerns Healthcare

Joerns Healthcare is a leading manufacturer and national service provider of patient handling and wound care products to the healthcare continuum. It helps healthcare providers solve complex medical equipment challenges, improve patient and caregiver safety, and speed patient healing with its renowned Purple Shirt service and efficient spend management. Headquartered in Charlotte, North Carolina with 1700 employees throughout North America and Europe, Joerns Healthcare is committed to delivering solutions that improve the lives of patients and care providers.

ProAct Pharmacy Services

ProAct Pharmacy Services is a Gouverneur, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Medical Technology Wristbands

Medical Technology Wristbands is a London, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Nikon Metris X-Tek Metrology Systems

Nikon Metris X-Tek Metrology Systems is a Brighton, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Reva Medical

Founded in 1998, REVA Medical is dedicated to developing minimally invasive medical devices that leverage its proprietary biomaterial and stent technologies to improve the treatment of coronary artery disease. Guided by an executive management team and scientific advisors with extensive product development and clinical interventional cardiology experience, REVA’s initial focus is the development of a drug-eluting bioresorbable coronary scaffold to advance the treatment of cardiovascular disease, the leading cause of death worldwide.